Sera Prognostics SERA
NASDAQ SERA
$2.11 +0.01 (+0.48%)
As of: Aug 21, 2026 · 3:59 PM EDT

Sera Prognostics (SERA) Net Margin Growth (5y) (2025 - 2026)

Sera Prognostics (SERA) Net Margin Growth (5y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn
10 Sera Prognostics 108.53 Mn 108.53 Mn -20,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.06 Mn
Mar 31, 2026 -2.14 Mn
Dec 31, 2025 3.69 Mn
Sep 30, 2025 2.23 Mn
Jun 30, 2025 542,059.00